Management of the non-toxic-appearing acutely febrile child: A 21st century approach

Journal of Pediatrics

Volumn 159, Issue 2, 2011, Pages 181-185

  Jhaveri, Ravi ^a   Byington, Carrie L ^b   Klein, Jerome O ^c   Shapiro, Eugene D ^d  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CEFTRIAXONE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; PNEUMOCOCCUS VACCINE; PROCALCITONIN;

ARTICLE; BACTEREMIA; BLOOD CULTURE; CHEMOPROPHYLAXIS; CHILD; CLINICAL PRACTICE; COST CONTROL; ENTEROVIRUS INFECTION; FEVER; HAEMOPHILUS INFLUENZAE TYPE B; HERPES SIMPLEX; HOSPITALIZATION; HUMAN; IMMUNIZATION; INFLUENZA B; LABORATORY TEST; LEUKOCYTE; LEUKOCYTE COUNT; MENINGITIS; MORTALITY; NEISSERIA MENINGITIDIS; NEUTROPHIL COUNT; NEWBORN PERIOD; PATIENT ASSESSMENT; PNEUMOCOCCAL INFECTION; PNEUMOCOCCAL MENINGITIS; POLYMERASE CHAIN REACTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS PNEUMONIAE; URINARY TRACT INFECTION; UROSEPSIS; VIRUS INFECTION;

ACUTE DISEASE; BACTERIAL INFECTIONS; CHILD; FEVER; HUMANS; INCIDENCE; PATIENT CARE MANAGEMENT; PRACTICE GUIDELINES AS TOPIC; RISK FACTORS; UNITED STATES;

EID: 79960441481     PISSN: 00223476     EISSN: 10976833     Source Type: Journal    
DOI: 10.1016/j.jpeds.2011.03.047     Document Type: Article

References (51)

1. M.S. Kramer, J. Etezadi-Amoli, A. Ciampi, S.M. Tange, K.N. Drummond, and E.L. Mills Parents' versus physicians' values for clinical outcomes in young febrile children Pediatrics 93 1994 697 702 (Pubitemid 24136098)
2. M.S. Kramer, and E.D. Shapiro Management of the young febrile child: a commentary on recent practice guidelines Pediatrics 100 1997 128 134 (Pubitemid 27291018)
3. K.B. Roberts Young, febrile infants: a 30-year odyssey ends where it started JAMA 291 2004 1261 1262 (Pubitemid 38541672)
4. G.M. Lee, G.R. Fleisher, and M.B. Harper Management of febrile children in the age of the conjugate pneumococcal vaccine: a cost-effectiveness analysis Pediatrics 108 2001 835 844 (Pubitemid 32947650)
5. E.R. Wald, and B. Dashefsky Cautionary note on the use of empiric ceftriaxone for suspected bacteremia Am J Dis Child 145 1991 1359 1361
6. R. Dagan, K.R. Powell, C.B. Hall, and M.A. Menegus Identification of infants unlikely to have serious bacterial infection although hospitalized for suspected sepsis J Pediatr 107 1985 855 860 (Pubitemid 16197090)
7. R. Dagan, S. Sofer, M. Phillip, and E. Shachak Ambulatory care of febrile infants younger than 2 months of age classified as being at low risk for having serious bacterial infections J Pediatr 112 1988 355 360 (Pubitemid 18079815)
8. L.J. Baraff, S.A. Oslund, D.L. Schriger, and M.L. Stephen Probability of bacterial infections in febrile infants less than three months of age: a meta-analysis Pediatr Infect Dis J 11 1992 257 264
9. K. Watt, E. Waddle, and R. Jhaveri Changing epidemiology of serious bacterial infections in febrile infants without localizing signs PLoS ONE 5 2010 e12448
10. R.H. Pantell, T.B. Newman, J. Bernzweig, D.A. Bergman, J.I. Takayama, and M. Segal Management and outcomes of care of fever in early infancy JAMA 291 2004 1203 1212 (Pubitemid 38541663)
11. J.E. McGowan Jr., L. Bratton, J.O. Klein, and M. Finland Bacteremia in febrile children seen in a "walk-in" pediatric clinic N Engl J Med 288 1973 1309 1312
12. G.R. Fleisher, N. Rosenberg, R. Vinci, J. Steinberg, K. Powell, and C. Christy Intramuscular versus oral antibiotic therapy for the prevention of meningitis and other bacterial sequelae in young, febrile children at risk for occult bacteremia J Pediatr 124 1994 504 512 (Pubitemid 24128143)
13. D.M. Jaffe, R.R. Tanz, A.T. Davis, F. Henretig, and G. Fleisher Antibiotic administration to treat possible occult bacteremia in febrile children N Engl J Med 317 1987 1175 1180 (Pubitemid 17150328)
14. D.W. Teele, R. Marshall, and J.O. Klein Unsuspected bacteremia in young children: a common and important problem Pediatr Clin North Am 26 1979 773 784 (Pubitemid 10160430)
15. L.J. Baraff, J.W. Bass, G.R. Fleisher, J.O. Klein, G.H. McCracken Jr., and K.R. Powell Practice guideline for the management of infants and children 0 to 36 months of age with fever without source. Agency for Health Care Policy and Research Ann Emerg Med 22 1993 1198 1210 (Pubitemid 23191038)
16. J.W. Bass, R.W. Steele, R.R. Wittler, M.E. Weisse, V. Bell, and A.H. Heisser Antimicrobial treatment of occult bacteremia: a multicenter cooperative study Pediatr Infect Dis J 12 1993 466 473 (Pubitemid 23173489)
17. M.S. Kramer, S.M. Tange, E.L. Mills, A. Ciampi, M.L. Bernstein, and K.N. Drummond Role of the complete blood count in detecting occult focal bacterial infection in the young febrile child J Clin Epidemiol 46 1993 349 357 (Pubitemid 23149052)
18. E.R. Alpern, E.A. Alessandrini, L.M. Bell, K.N. Shaw, and K.L. McGowan Occult bacteremia from a pediatric emergency department: current prevalence, time to detection, and outcome Pediatrics 106 2000 505 511 (Pubitemid 30664136)
19. E.D. Shapiro, N.H. Aaron, E.R. Wald, and D. Chiponis Risk factors for development of bacterial meningitis among children with occult bacteremia J Pediatr 109 1986 15 19 (Pubitemid 16099834)
20. Progress toward elimination of Haemophilus influenzae type B disease among infants and children - United States, 1987-1995 MMWR Morb Mortal Wkly Rep 45 1996 901 906
21. Invasive pneumococcal disease in children 5 years after conjugate vaccine introduction - eight states, 1998-2005 MMWR Morb Mortal Wkly Rep 57 2008 144 148
22. Licensure of a 13-valent pneumococcal conjugate vaccine (PCV13) and recommendations for use among children - Advisory Committee on Immunization Practices (ACIP), 2010 MMWR Morb Mortal Wkly Rep 59 2010 258 261
23. Prevention of perinatal group B streptococcal disease - revised guidelines from CDC, 2010 MMWR Recomm Rep 59 RR-10 2010 1 36
24. A. Fernandez Lopez, C. Luaces Cubells, J.J. Garcia Garcia, and J. Fernandez Pou Procalcitonin in pediatric emergency departments for the early diagnosis of invasive bacterial infections in febrile infants: results of a multicenter study and utility of a rapid qualitative test for this marker Pediatr Infect Dis J 22 2003 895 903 (Pubitemid 37288613)
25. B. Andreola, S. Bressan, S. Callegaro, A. Liverani, M. Plebani, and L. Da Dalt Procalcitonin and C-reactive protein as diagnostic markers of severe bacterial infections in febrile infants and children in the emergency department Pediatr Infect Dis J 26 2007 672 677 (Pubitemid 47424634)
26. E. Bilavsky, H. Yarden-Bilavsky, J. Amir, and S. Ashkenazi Should complete blood count be part of the evaluation of febrile infants aged ≤2 months? Acta Paediatr 99 2010 1380 1384
27. D. Gendrel, and C. Bohuon Procalcitonin in pediatrics for differentiation of bacterial and viral infections Intensive Care Med 26 Suppl 2 2000 S178 S181
28. C.L. Byington, F.R. Enriquez, C. Hoff, R. Tuohy, E.W. Taggart, and D.R. Hillyard Serious bacterial infections in febrile infants 1 to 90 days old with and without viral infections Pediatrics 113 2004 1662 1666 (Pubitemid 38697973)
29. J.M. Bender, K. Ampofo, P. Gesteland, X. Sheng, K. Korgenski, and B. Raines Influenza virus infection in infants less than three months of age Pediatr Infect Dis J 29 2010 6 9
30. W.I. Krief, D.A. Levine, S.L. Platt, C.G. Macias, P.S. Dayan, and J.J. Zorc Influenza virus infection and the risk of serious bacterial infections in young febrile infants Pediatrics 124 2009 30 39
31. K.R. Rittichier, P.A. Bryan, K.E. Bassett, E.W. Taggart, F.R. Enriquez, and D.R. Hillyard Diagnosis and outcomes of enterovirus infections in young infants Pediatr Infect Dis J 24 2005 546 550 (Pubitemid 40847530)
32. D.A. Levine, S.L. Platt, P.S. Dayan, C.G. Macias, J.J. Zorc, and W. Krief Risk of serious bacterial infection in young febrile infants with respiratory syncytial virus infections Pediatrics 113 2004 1728 1734 (Pubitemid 38697983)
33. C. Ramers, G. Billman, M. Hartin, S. Ho, and M.H. Sawyer Impact of a diagnostic cerebrospinal fluid enterovirus polymerase chain reaction test on patient management JAMA 283 2000 2680 2685 (Pubitemid 30337330)
34. J. Benito-Fernandez, M.A. Vazquez-Ronco, E. Morteruel-Aizkuren, S. Mintegui-Raso, J. Sanchez-Etxaniz, and A. Fernandez-Landaluce Impact of rapid viral testing for influenza A and B viruses on management of febrile infants without signs of focal infection Pediatr Infect Dis J 25 2006 1153 1157 (Pubitemid 44900679)
35. Clinical policy for children younger than three years presenting to the emergency department with fever Ann Emerg Med 42 2003 530 545
36. E.R. Alpern, E.A. Alessandrini, K.L. McGowan, L.M. Bell, and K.N. Shaw Serotype prevalence of occult pneumococcal bacteremia Pediatrics 108 2001 e23
37. M.L. Stoll, and L.G. Rubin Incidence of occult bacteremia among highly febrile young children in the era of the pneumococcal conjugate vaccine: a study from a children's hospital emergency department and urgent care center Arch Pediatr Adolesc Med 158 2004 671 675 (Pubitemid 38886493)
38. K.L. Carstairs, D.A. Tanen, A.S. Johnson, S.B. Kailes, and R.H. Riffenburgh Pneumococcal bacteremia in febrile infants presenting to the emergency department before and after the introduction of the heptavalent pneumococcal vaccine Ann Emerg Med 49 2007 772 777 (Pubitemid 46755436)
39. B. Sard, M.C. Bailey, and R. Vinci An analysis of pediatric blood cultures in the postpneumococcal conjugate vaccine era in a community hospital emergency department Pediatr Emerg Care 22 2006 295 300 (Pubitemid 43832782)
40. E. Waddle, and R. Jhaveri Outcomes of febrile children without localising signs after pneumococcal conjugate vaccine Arch Dis Child 94 2009 144 147
41. M. Wilkinson, B. Bulloch, and M. Smith Prevalence of occult bacteremia in children aged 3 to 36 months presenting to the emergency department with fever in the postpneumococcal conjugate vaccine era Acad Emerg Med 16 2009 220 225
42. Kaplan SL, Barson WJ, Lin PL, Stovall SH, Bradley JS, Tan TQ, et al. Serotype 19A is the most common serotype causing invasive pneumococcal infections in children. Pediatrics;125:429-36.
43. A.C. Cohn, J.R. MacNeil, L.H. Harrison, C. Hatcher, J. Theodore, and M. Schmidt Changes in Neisseria meningitidis disease epidemiology in the United States, 1998-2007: implications for prevention of meningococcal disease Clin Infect Dis 50 2010 184 191
44. K.B. Roberts, E. Charney, R.J. Sweren, V.I. Ahonkhai, D.A. Bergman, and M.P. Coulter Urinary tract infection in infants with unexplained fever: a collaborative study J Pediatr 103 1983 864 867 (Pubitemid 14204175)
45. American Academy of Pediatrics, Committee on Quality Improvement, Subcommittee on Urinary Tract Infection Practice parameter: the diagnosis, treatment, and evaluation of the initial urinary tract infection in febrile infants and young children Pediatrics 103 4 Pt 1 1999 843 852
46. M. Harmsen, E.M. Adang, R.J. Wolters, J.C. van der Wouden, R.P. Grol, and M. Wensing Management of childhood urinary tract infections: an economic modeling study Value Health 12 2009 466 472
47. A.C. Caviness, G.J. Demmler, and B.J. Selwyn Clinical and laboratory features of neonatal herpes simplex virus infection: a case-control study Pediatr Infect Dis J 27 2008 425 430
48. A.C. Caviness, G.J. Demmler, Y. Almendarez, and B.J. Selwyn The prevalence of neonatal herpes simplex virus infection compared with serious bacterial illness in hospitalized neonates J Pediatr 153 2008 164 169
49. L.J. Baraff Management of infants and young children with fever without source Pediatr Ann 37 2008 673 679
50. P. Ishimine Fever without source in children 0 to 36 months of age Pediatr Clin North Am 53 2006 167 194
51. National Institute for Health and Clinical Excellence, Centre for Clinical Practice. Review of clinical guideline CG47: feverish illness in children: assessment and initial management in children younger than 5 years. Available from: http://www.nice.org.uk/nicemedia/live/11010/51791/51791.pdf. Accessed July 6, 2010.